Clint R Carroll1, Carolyn Noonan2, Eva M Garroutte3, Ana Navas-Acien4, Steven P Verney5, Dedra Buchwald2. 1. Department of Ethnic Studies, University of Colorado, Boulder, CO, USA. Electronic address: clint.carroll@colorado.edu. 2. Initiative for Research and Education to Advance Community Health (IREACH), Washington State University, Spokane, WA, USA. 3. Department of Sociology, Boston College, Chestnut Hill, MA, USA. 4. Departments of Environmental Health Sciences and Epidemiology, Columbia University, New York, NY, USA. 5. Department of Psychology, University of New Mexico, Albuquerque, NM, USA.
Abstract
BACKGROUND: Inorganic arsenic at high and prolonged doses is highly neurotoxic. Few studies have evaluated whether long-term, low-level arsenic exposure is associated with neuropsychological functioning in adults. OBJECTIVES: To investigate the association between long-term, low-level inorganic arsenic exposure and neuropsychological functioning among American Indians aged 64-95. METHODS: We assessed 928 participants in the Strong Heart Study by using data on arsenic species in urine samples collected at baseline (1989-1991) and results of standardized tests of global cognition, executive functioning, verbal learning and memory, fine motor functioning, and speed of mental processing administered during comprehensive follow-up evaluations in 2009-2013. We calculated the difference in neuropsychological functioning for a 10% increase in urinary arsenic with adjustment for sex, age, education, and study site. RESULTS: The sum of inorganic and methylated arsenic species (∑As) in urine was associated with limited fine motor functioning and processing speed. A 10% increase in ∑As was associated with a .10 (95% CI -.20, -.01) decrease on the Finger Tapping Test for the dominant hand and a .13 decrease (95% CI -.21, -.04) for the non-dominant hand. Similarly, a 10% increase in ∑As was associated with a .15 (95% CI -.29, .00) decrease on the Wechsler Adult Intelligence Scale-Fourth Edition Coding Subtest. ∑As was not associated with other neuropsychological functions. CONCLUSIONS: Findings indicate an adverse association between increased urinary arsenic fine motor functioning and processing speed, but not with other neuropsychological functioning, among elderly American Indians.
BACKGROUND:Inorganic arsenic at high and prolonged doses is highly neurotoxic. Few studies have evaluated whether long-term, low-level arsenic exposure is associated with neuropsychological functioning in adults. OBJECTIVES: To investigate the association between long-term, low-level inorganic arsenic exposure and neuropsychological functioning among American Indians aged 64-95. METHODS: We assessed 928 participants in the Strong Heart Study by using data on arsenic species in urine samples collected at baseline (1989-1991) and results of standardized tests of global cognition, executive functioning, verbal learning and memory, fine motor functioning, and speed of mental processing administered during comprehensive follow-up evaluations in 2009-2013. We calculated the difference in neuropsychological functioning for a 10% increase in urinary arsenic with adjustment for sex, age, education, and study site. RESULTS: The sum of inorganic and methylated arsenic species (∑As) in urine was associated with limited fine motor functioning and processing speed. A 10% increase in ∑As was associated with a .10 (95% CI -.20, -.01) decrease on the Finger Tapping Test for the dominant hand and a .13 decrease (95% CI -.21, -.04) for the non-dominant hand. Similarly, a 10% increase in ∑As was associated with a .15 (95% CI -.29, .00) decrease on the Wechsler Adult Intelligence Scale-Fourth Edition Coding Subtest. ∑As was not associated with other neuropsychological functions. CONCLUSIONS: Findings indicate an adverse association between increased urinary arsenic fine motor functioning and processing speed, but not with other neuropsychological functioning, among elderly American Indians.
Authors: Esther García-Esquinas; Marina Pollán; Jason G Umans; Kevin A Francesconi; Walter Goessler; Eliseo Guallar; Barbara Howard; John Farley; Lyle G Best; Ana Navas-Acien Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-10-17 Impact factor: 4.254
Authors: W D Rosamond; A R Folsom; L E Chambless; C H Wang; P G McGovern; G Howard; L S Copper; E Shahar Journal: Stroke Date: 1999-04 Impact factor: 7.914
Authors: Robert O Wright; Chitra Amarasiriwardena; Alan D Woolf; Rebecca Jim; David C Bellinger Journal: Neurotoxicology Date: 2005-11-28 Impact factor: 4.294
Authors: Matthew O Gribble; Barbara V Howard; Jason G Umans; Nawar M Shara; Kevin A Francesconi; Walter Goessler; Ciprian M Crainiceanu; Ellen K Silbergeld; Eliseo Guallar; Ana Navas-Acien Journal: Am J Epidemiol Date: 2012-10-24 Impact factor: 4.897
Authors: Katherine A Moon; Eliseo Guallar; Jason G Umans; Richard B Devereux; Lyle G Best; Kevin A Francesconi; Walter Goessler; Jonathan Pollak; Ellen K Silbergeld; Barbara V Howard; Ana Navas-Acien Journal: Ann Intern Med Date: 2013-11-19 Impact factor: 25.391
Authors: Jorge L Rosado; Dolores Ronquillo; Katarzyna Kordas; Olga Rojas; Javier Alatorre; Patricia Lopez; Gonzalo Garcia-Vargas; María Del Carmen Caamaño; Mariano E Cebrián; Rebecca J Stoltzfus Journal: Environ Health Perspect Date: 2007-09 Impact factor: 9.031
Authors: Kevin K Caldwell; Alexander Hafez; Elizabeth Solomon; Matthew Cunningham; Andrea M Allan Journal: Neurotoxicol Teratol Date: 2017-11-11 Impact factor: 3.763
Authors: Astrid Suchy-Dicey; Carolyn Noonan; Ekaterina Burduli; Farrah J Mateen; W T Longstreth; Dedra Buchwald; Ana Navas-Acien Journal: Environ Health Perspect Date: 2020-12-17 Impact factor: 9.031